Free Trial

Research Analysts Set Expectations for SunOpta Q2 Earnings

SunOpta logo with Consumer Staples background

SunOpta Inc. (NASDAQ:STKL - Free Report) TSE: SOY - William Blair boosted their Q2 2025 EPS estimates for shares of SunOpta in a research note issued to investors on Thursday, May 8th. William Blair analyst J. Andersen now forecasts that the company will earn $0.02 per share for the quarter, up from their previous estimate of $0.01. The consensus estimate for SunOpta's current full-year earnings is $0.13 per share. William Blair also issued estimates for SunOpta's FY2025 earnings at $0.19 EPS.

Separately, StockNews.com upgraded shares of SunOpta from a "sell" rating to a "hold" rating in a research note on Tuesday, March 11th.

Check Out Our Latest Stock Analysis on SunOpta

SunOpta Stock Up 0.2%

Shares of SunOpta stock traded up $0.02 during trading on Monday, hitting $6.21. 86,778 shares of the stock traded hands, compared to its average volume of 760,635. The stock has a market cap of $729.35 million, a P/E ratio of -34.47 and a beta of 1.50. The company has a fifty day moving average price of $4.75 and a two-hundred day moving average price of $6.44. SunOpta has a twelve month low of $3.65 and a twelve month high of $8.11. The company has a debt-to-equity ratio of 1.61, a quick ratio of 0.53 and a current ratio of 1.20.

SunOpta (NASDAQ:STKL - Get Free Report) TSE: SOY last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.04 earnings per share for the quarter, topping analysts' consensus estimates of $0.02 by $0.02. The business had revenue of $201.63 million for the quarter, compared to the consensus estimate of $195.09 million. SunOpta had a negative net margin of 2.74% and a positive return on equity of 7.92%.

Institutional Investors Weigh In On SunOpta

Several institutional investors and hedge funds have recently added to or reduced their stakes in STKL. Quarry LP bought a new position in shares of SunOpta in the fourth quarter valued at approximately $36,000. D.A. Davidson & CO. bought a new position in SunOpta in the 4th quarter worth $81,000. Bayesian Capital Management LP raised its holdings in SunOpta by 15.2% in the 4th quarter. Bayesian Capital Management LP now owns 11,536 shares of the company's stock worth $89,000 after acquiring an additional 1,523 shares during the period. Mutual Advisors LLC acquired a new position in SunOpta during the 4th quarter worth $92,000. Finally, Quadrant Capital Group LLC boosted its holdings in SunOpta by 15.2% during the fourth quarter. Quadrant Capital Group LLC now owns 14,542 shares of the company's stock valued at $112,000 after acquiring an additional 1,923 shares during the period. 85.39% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at SunOpta

In other news, SVP Bryan P. Clark sold 8,500 shares of the company's stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $5.32, for a total transaction of $45,220.00. Following the completion of the sale, the senior vice president now owns 28,150 shares in the company, valued at approximately $149,758. This represents a 23.19% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.90% of the company's stock.

About SunOpta

(Get Free Report)

SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.

Further Reading

Should You Invest $1,000 in SunOpta Right Now?

Before you consider SunOpta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SunOpta wasn't on the list.

While SunOpta currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA
This Unique Robotaxi Play Could Deliver 10X Returns

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines